β2-Adrenergic receptors in immunity and inflammation: Stressing NF-κB
暂无分享,去创建一个
Jan Tavernier | J. Tavernier | Krzysztof Kolmus | Sarah Gerlo | S. Gerlo | Krzysztof Kolmus | Sarah Gerlo
[1] S. Peters,et al. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. , 2006, Blood.
[2] Marc Montminy,et al. Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.
[3] B. Crossett,et al. Characterising the Mechanism of Airway Smooth Muscle β2 Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells , 2013, PloS one.
[4] G. Canonica,et al. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB. , 2005, International immunology.
[5] R. Lefkowitz,et al. β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα , 2004 .
[6] R. Lefkowitz,et al. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Ghosh,et al. Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.
[8] Priyanka Rathore,et al. Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies , 2011, Journal of Neuroinflammation.
[9] S. Cole,et al. A Functional Genomic Fingerprint of Chronic Stress in Humans: Blunted Glucocorticoid and Increased NF-κB Signaling , 2008, Biological Psychiatry.
[10] J. Cidlowski,et al. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.
[11] W. Koch,et al. Impaired neoangiogenesis in β2–adrenoceptor gene‐deficient mice: restoration by intravascular human β2–adrenoceptor gene transfer and role of NFκB and CREB transcription factors , 2011, British journal of pharmacology.
[12] B. Kobilka. Structural insights into adrenergic receptor function and pharmacology. , 2011, Trends in pharmacological sciences.
[13] Michael C. Ostrowski,et al. A nuclear factor that binds to ras-responsive enhancer elements is present in human tumor cells. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] E. Krebs,et al. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. , 1968, The Journal of biological chemistry.
[15] J. Pugin,et al. beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[16] J. Bos. Epac: a new cAMP target and new avenues in cAMP research , 2003, Nature Reviews Molecular Cell Biology.
[17] T. Loop,et al. Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-&kgr;B in Human T Lymphocytes In Vitro , 2004, Anesthesia and analgesia.
[18] G. Chrousos,et al. Stress System – Organization, Physiology and Immunoregulation , 2007, Neuroimmunomodulation.
[19] L. Gentilello,et al. Could Beta blockade improve outcome after injury by modulating inflammatory profiles? , 2008, The Journal of trauma.
[20] S. Pyo,et al. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages. , 2011, Cellular signalling.
[21] G. Canonica,et al. Lung myofibroblasts as targets of salmeterol and fluticasone propionate : inhibition of α-SMA and NF-κB , 2005 .
[22] Steven W. Cole,et al. Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.
[23] M. Karin,et al. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. , 2014, Seminars in immunology.
[24] M. Philipp,et al. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. , 2004, Pharmacology & therapeutics.
[25] J. Violin,et al. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Chang,et al. Carvedilol, a new antioxidative β-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-κB activity , 2003 .
[27] Robert J. Lefkowitz,et al. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.
[28] B. Rozec,et al. β2-Adrenoreceptor Agonist Inhibits Antigen Cross-Presentation by Dendritic Cells , 2013, The Journal of Immunology.
[29] Prahlad T. Ram,et al. G Protein Pathways , 2002, Science.
[30] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[31] R. Ader,et al. Brain, behavior, and immunity , 1987, Brain, Behavior, and Immunity.
[32] S. Ghosh,et al. Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes , 2014, Front. Immunol..
[33] E. Johns,et al. Activation of (cid:1) 2 -Adrenoceptor Prevents Shiga Toxin 2-Induced TNF- (cid:2) Gene Transcription , 2001 .
[34] C. Hung,et al. Inhibitory effects of albuterol and fenoterol on RANTES and IP‐10 expression in bronchial epithelial cells , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[35] Shau-ku Huang,et al. MAPK-dependent regulation of IL-1- and β-adrenoreceptor-induced inflammatory cytokine production from mast cells: Implications for the stress response , 2004, BMC Immunology.
[36] D. Feinstein,et al. A 27‐bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells , 2001, Journal of neurochemistry.
[37] S. Smale. Hierarchies of NF-κB target-gene regulation , 2011, Nature Immunology.
[38] V. Sanders,et al. Neuroendocrine regulation of inflammation. , 2014, Seminars in immunology.
[39] K. Chung,et al. Effect of (cid:1) 2 -adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A , 2008 .
[40] A. Hoffmann,et al. CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. , 2003, Molecular cell.
[41] G. O'Neill,et al. Tumor Necrosis Factor- α –Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells: Modulation by Glucocorticoids and β -Agonists , 2002 .
[42] Malcolm W Johnson. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation , 2006 .
[43] Tianyi Zhu,et al. Salmeterol attenuates the inflammatory response in asthma and decreases the pro-inflammatory cytokine secretion of dendritic cells , 2012, Cellular and Molecular Immunology.
[44] K. Ryan,et al. Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: A role for IκB , 2013, Neurochemistry International.
[45] D. Feinstein,et al. Norepinephrine Increases IκBα Expression in Astrocytes* , 2002, The Journal of Biological Chemistry.
[46] R. Isseroff,et al. beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. , 2006, The Journal of biological chemistry.
[47] E. Lakatta,et al. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.
[48] B. Kobilka,et al. β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes* , 2000, The Journal of Biological Chemistry.
[49] H. Erdjument-Bromage,et al. The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.
[50] Ming Xu,et al. Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line , 2009, Acta Pharmacologica Sinica.
[51] W. V. Berghe,et al. Cross-talk between nuclear receptors and nuclear factor κB , 2006, Oncogene.
[52] A. Richmond. Nf-kappa B, chemokine gene transcription and tumour growth. , 2002, Nature reviews. Immunology.
[53] J. Aerts,et al. β2-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations , 2014, Journal of Neuroinflammation.
[54] R. Stevens,et al. GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.
[55] Markus Schwaninger,et al. A mechanism converting psychosocial stress into mononuclear cell activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[56] Sankar Ghosh,et al. NF-κB, the first quarter-century: remarkable progress and outstanding questions. , 2012, Genes & development.
[57] H. Kubo,et al. Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells , 2013, Physiological reports.
[58] Malcolm W Johnson. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. , 2006, The Journal of allergy and clinical immunology.
[59] M. Cazzola,et al. β2‐adrenoceptor agonists: current and future direction , 2011, British journal of pharmacology.
[60] T. Maniatis,et al. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. , 1997, Molecular cell.
[61] D. Annane,et al. Bench-to-bedside review: β-Adrenergic modulation in sepsis , 2009, Critical care.
[62] G. Haegeman,et al. IL-1β potently stabilizes IL-6 mRNA in human astrocytes. , 2011, Biochemical pharmacology.
[63] T. Lawrence. The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.
[64] D. Feinstein,et al. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1β production , 2004, Journal of Neuroinflammation.
[65] N. Mackman,et al. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. , 1997, Journal of immunology.
[66] G. Haegeman,et al. The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter* , 1999, The Journal of Biological Chemistry.
[67] J. V. Sarma,et al. Anti‐inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] M. Karin,et al. NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.
[69] B. Brüne,et al. Neuromediators in inflammation--a macrophage/nerve connection. , 2010, Immunobiology.
[70] T. Gilmore,et al. Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.
[71] Robert J. Lefkowitz,et al. A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling , 2007, Proceedings of the National Academy of Sciences.
[72] Ronald Anderson,et al. Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? , 2013, Drug design, development and therapy.
[73] C. Hung,et al. Effect of procaterol on Th2‐related chemokines production in human monocyte and bronchial epithelial cells , 2010, Pediatric pulmonology.
[74] G. Haegeman,et al. Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. , 2006, Biochemical pharmacology.
[75] Yue Sun,et al. Identification of-Arrestin 2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-B Pathways , 2004 .
[76] Gioacchino Natoli,et al. Interactions of NF-κB with chromatin: the art of being at the right place at the right time , 2005, Nature Immunology.
[77] Jiuhong Kang,et al. β‐Arrestin2 functions as a phosphorylation‐regulated suppressor of UV‐induced NF‐κB activation , 2005 .
[78] Y. Le,et al. Norepinephrine Promotes Microglia to Uptake and Degrade Amyloid β Peptide through Upregulation of Mouse Formyl Peptide Receptor 2 and Induction of Insulin-Degrading Enzyme , 2010, The Journal of Neuroscience.
[79] G. Bai,et al. The synergistic anti-asthmatic effects of glycyrrhizin and salbutamol , 2010, Acta Pharmacologica Sinica.
[80] Z. Korade,et al. Protein Kinase A-Induced Phosphorylation of the p65 Subunit of Nuclear Factor-κB Promotes Schwann Cell Differentiation into a Myelinating Phenotype , 2008, The Journal of Neuroscience.
[81] K. Ryan,et al. Noradrenaline acting at β-adrenoceptors induces expression of IL-1β and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex , 2010, Neuropharmacology.
[82] D. Feinstein,et al. Norepinephrine increases I kappa B alpha expression in astrocytes. , 2002, The Journal of biological chemistry.
[83] B. Chandrasekar,et al. β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB , 2004 .
[84] C. Hung,et al. Suppressive Effects of Procaterol on Expression of IP-10/CXCL 10 and RANTES/CCL 5 by Bronchial Epithelial Cells , 2011, Inflammation.
[85] T. Connor,et al. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. , 2009, The international journal of neuropsychopharmacology.
[86] R. Giffard,et al. Postischemic Brain Injury Is Attenuated in Mice Lacking the &bgr;2-Adrenergic Receptor , 2009, Anesthesia and analgesia.
[87] S. Ghosh,et al. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.
[88] Chun Xing Li,et al. Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. , 2006, Journal of molecular and cellular cardiology.
[89] H. Erdjument-Bromage,et al. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. , 1997, Cell.
[90] R. Lefkowitz,et al. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. , 2006, Molecular cell.
[91] A. Halayko,et al. Anti-Inflammatory Role of the cAMP Effectors Epac and PKA: Implications in Chronic Obstructive Pulmonary Disease , 2012, PloS one.
[92] J. Bos,et al. Epac: defining a new mechanism for cAMP action. , 2010, Annual review of pharmacology and toxicology.
[93] Bernie J Daigle,et al. Mice lacking the β2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia , 2012, ASN neuro.
[94] E. Sternberg. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens , 2006, Nature Reviews Immunology.
[95] J. Tavernier,et al. β-Agonists Selectively Modulate Proinflammatory Gene Expression in Skeletal Muscle Cells via Non-Canonical Nuclear Crosstalk Mechanisms , 2014, PloS one.
[96] B. Chandrasekar,et al. Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement. , 2012, Differentiation; research in biological diversity.
[97] C. Lang,et al. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. , 2004, American journal of physiology. Endocrinology and metabolism.
[98] D. Chang,et al. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. , 2003, Cardiovascular research.
[99] Jiuhong Kang,et al. Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. , 2005, The EMBO journal.
[100] A. Knox,et al. Differential Regulation of Chemokine Expression by Peroxisome Proliferator-activated Receptor γ Agonists , 2005, Journal of Biological Chemistry.
[101] P. Mantyh,et al. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[102] G. O'Neill,et al. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. , 2002, American Journal of Respiratory Cell and Molecular Biology.
[103] K. Zänker,et al. Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes , 2009, BMC Immunology.
[104] Yue Sun,et al. Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways , 2004 .
[105] R. Lefkowitz,et al. β-Arrestin-mediated receptor trafficking and signal transduction. , 2011, Trends in pharmacological sciences.
[106] D. Feinstein,et al. Effects of noradrenaline on neuronal NOS2 expression and viability. , 2006, Antioxidants & redox signaling.
[107] D. Herndon,et al. Long-Term Persistance of the Pathophysiologic Response to Severe Burn Injury , 2011, PloS one.
[108] T. Okamoto,et al. A-kinase-interacting Protein 1 (AKIP1) Acts as a Molecular Determinant of PKA in NF-κB Signaling , 2010, The Journal of Biological Chemistry.
[109] Sunila Hussain. Inflammation and cancer: is AID aiding? , 2008, Gastroenterology.
[110] M. Hecker,et al. Targeting Activation of Specific NF-κB Subunits Prevents Stress-Dependent Atherothrombotic Gene Expression , 2012, Molecular medicine.
[111] A. Wittinghofer,et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.
[112] N. Dogan,et al. Experimental acute lung injury. Effects of methylprednisolone and lidocaine on histopathology and neutrophils. , 2004, Saudi medical journal.
[113] M. Bouvier,et al. Ligand bias prevents class equality among beta-blockers. , 2014, Current opinion in pharmacology.
[114] V. Sanders. The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet? , 2012, Brain, Behavior, and Immunity.
[115] R. Jockers,et al. GPCR-interacting proteins, major players of GPCR function. , 2011, Advances in pharmacology.
[116] Lan Ma,et al. β-arrestin signaling and regulation of transcription , 2007, Journal of Cell Science.
[117] N. Perkins. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.
[118] A. Bruzzone,et al. Dosage‐dependent regulation of cell proliferation and adhesion through dual β2‐adrenergic receptor/cAMP signals , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[119] G. Folkerts,et al. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke , 2008, Journal of Molecular Medicine.
[120] A. Knox,et al. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. , 2005, The Journal of biological chemistry.
[121] J. Pugin,et al. β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway , 2000 .
[122] J. Padbury,et al. A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. , 2007, American journal of physiology. Heart and circulatory physiology.
[123] G. Chrousos,et al. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.
[124] J. Sheridan,et al. Psychosocial stress and inflammation in cancer , 2013, Brain, Behavior, and Immunity.
[125] A. Hoffmann,et al. CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response , 2003 .
[126] G. Haegeman,et al. Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. , 2010, Cellular signalling.
[127] G. Haegeman,et al. Cross-talk between nuclear receptors and nuclear factor kappaB. , 2006, Oncogene.
[128] R. Wunderink,et al. β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. , 2014, The Journal of clinical investigation.
[129] Arthur Christopoulos,et al. Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy , 2014, Molecular Pharmacology.
[130] M. Naumann,et al. Beyond IκBs: alternative regulation of NF‐KB activity , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[131] G. Haegeman,et al. Hunting for Serine 276-Phosphorylated p65 , 2010, Journal of biomedicine & biotechnology.
[132] Paul H. Black,et al. Stress and the inflammatory response: A review of neurogenic inflammation , 2002, Brain, Behavior, and Immunity.
[133] V. Sanders,et al. B Cell Receptor- and β2-Adrenergic Receptor-Induced Regulation of B7-2 (CD86) Expression in B Cells1 , 2002, The Journal of Immunology.
[134] P. Sharp,et al. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.
[135] Burn size determines the inflammatory and hypermetabolic response , 2007, Critical Care.
[136] S. Ghosh,et al. NF-κB, inflammation, and metabolic disease. , 2011, Cell metabolism.
[137] S. Ghosh,et al. NF-κB in immunobiology , 2011, Cell Research.